Breaking

Florinda Ashbridge

User Account Blocked by Social Media Platform
Research Drops

User Account Blocked by Social Media Platform

Medicaid costs rise with late-stage cancer, study links Medicaid claims to cancer stage and spending patterns, affecting healthcare access.

Florinda Ashbridge · August 10, 2026
User Blocked from Accessing Online Service
Daily Health

User Blocked from Accessing Online Service

Closing the women's health gap with a $20 billion federal investment in women's health research and care.

Florinda Ashbridge · August 10, 2026
Users report website access blocked
Wellness Moves

Users report website access blocked

Adding high-dose vitamin d3 chemotherapy failed to improve progression-free survival for metastatic colorectal cancer patients in the SOLARIS trial.

Florinda Ashbridge · August 7, 2026
User Blocked by Social Media Platform
Drug Watch

User Blocked by Social Media Platform

Understanding lymphoma trial results and progression-free survival data for better treatment decisions and quality of life.

Florinda Ashbridge · August 6, 2026
User Blocked from Social Media Platform
Research Drops

User Blocked from Social Media Platform

Interstitial lung disease diagnosis is often delayed due to overlapping symptoms with asthma and heart failure, requiring physicians to spot subtle clues…

Florinda Ashbridge · August 6, 2026
User Blocked After Repeated Policy Violations
Research Drops

User Blocked After Repeated Policy Violations

Retatrutide access opens as Eli Lilly launches a compassionate‑use program for patients unable to join clinical trials, awaiting FDA approval soon.

Florinda Ashbridge · August 6, 2026
User access blocked by platform
Research Drops

User access blocked by platform

Oncologists face insurance delays and logistical hurdles blocking access to advanced cancer treatments like CAR T-cell therapy.

Florinda Ashbridge · August 4, 2026
User Blocked After Policy Violation
Daily Health

User Blocked After Policy Violation

The multiple myeloma trial reveals an 89% lower risk of disease progression or death with the teclistamab‑talquetamab combo, offering new hope for…

Florinda Ashbridge · August 2, 2026
User access blocked due to error
Daily Health

User access blocked due to error

Patients with MASLD or MASH face higher risks of mild cognitive impairment. Learn about the latest study linking liver disease to cognitive…

Florinda Ashbridge · July 31, 2026
User Blocked After Violation of Platform Policies
Daily Health

User Blocked After Violation of Platform Policies

Wildfire smoke asthma risk rises as dense plumes degrade air quality across the Pacific Northwest, prompting emergency health guidance for sufferers and…

Florinda Ashbridge · July 30, 2026